San Jose, CA, November 16, 2008 --(PR.com
)-- In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class 10,000 clean rooms.
“The need for GMP-grade peptides is growing,” stated AnaSpec CEO, Dr. Frank Hong. “The expansion of our dedicated GMP manufacturing facilities will allow us to more fully address the stringent requirements of our customers.”
AnaSpec offers GMP peptides in milligram to kilogram quantities. Optimized for bulk API manufacturing, AnaSpec’s GMP peptide services offer >98% purity peptides with QC product release testing, stability studies, and full documentation for drug master files.
AnaSpec is a leading provider of integrated proteomics solutions to the world’s largest pharmaceutical, biotech, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents (including fluorescent dyes, antibodies, and assay kits), and combinatorial chemistry.
For more information visit www.anaspec.com